Pfizer Inc. (JOBS) Eyes Takeovers to Boost Generics Unit

March 19, 2009 |

1 min read

FRANKFURT, March 19 (Reuters) - U.S. drugs giant Pfizer Inc. is eyeing takeovers as a way to boost its generics business, German business daily Handeslblatt quoted a top company executive as saying.

Mergers & acquisitions Europe

Pfizer

MORE ON THIS TOPIC

Business people shaking hand in China.

Obesity

AstraZeneca’s China Trip Yields CSPC Obesity Deal Worth $1.2B Upfront

January 30, 2026

·

2 min read

·

Tristan Manalac

Array of piggy banks in saturated colours on high colour contrast background. Illustration of the concept of bank savings, financial investment and multiple sources of income

Insights

Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026

January 29, 2026

·

3 min read

·

Jennifer Smith-Parker

Handshake in retro collage style. Hands with halftone effect make a deal, a hand comes out of a laptop, online deals. Vector modern illustration.

Immunology and inflammation

Lilly Establishes up to $1.9B Repertoire Deal in Second Immune Play of 2026

January 29, 2026

·

2 min read

·

Tristan Manalac

Insights

Biotech’s New Cycle, JPM Deal Hype and Where Alpha Still Hides

January 29, 2026

·

1 min read

·

Jennifer Smith-Parker